Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Multiple Sclerosis

  Free Subscription


1 Arch Phys Med Rehabil
1 BMC Neurol
1 Eur Neurol
1 Int J Neurosci
1 J Neuroimmunol
1 J Neurol
2 Magn Reson Med
2 Mult Scler
1 Nat Med
2 Neurology
1 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Arch Phys Med Rehabil

  1. MANCA A, Ventura L, Martinez G, Cano A, et al
    Energy expenditure and oxygen consumption during activities of daily living in people with multiple sclerosis and healthy subjects: an ecological approach to estimate real-life fatigue and fatigability.
    Arch Phys Med Rehabil. 2021 Feb 1. pii: S0003-9993(21)00094.
    PubMed         Abstract available

    BMC Neurol

  2. DELGADO S, Hernandez J, Tornes L, Rammohan K, et al
    Increased multiple sclerosis disease activity in patients transitioned from fingolimod to dimethyl fumarate: a case series.
    BMC Neurol. 2021;21:48.
    PubMed         Abstract available

    Eur Neurol

  3. DEL BRUTTO OH, Mera RM, Costa AF, Silva P, et al
    Dawson Fingers in Older Adults with Cerebral Small Vessel Disease: A Population Study.
    Eur Neurol. 2020;83:421-425.
    PubMed         Abstract available

    Int J Neurosci

  4. DOSKAS T, Vavougios DG, Karampetsou P, Kormas C, et al
    Neurocognitive Impairment and Social Cognition in Multiple Sclerosis.
    Int J Neurosci. 2021 Feb 2:1-26. doi: 10.1080/00207454.2021.1879066.
    PubMed         Abstract available

    J Neuroimmunol

  5. MIMPEN M, Rolf L, Muris AH, Gerlach O, et al
    NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis.
    J Neuroimmunol. 2021;353:577499.
    PubMed         Abstract available

    J Neurol

  6. TREABA CA, Herranz E, Barletta VT, Mehndiratta A, et al
    The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI.
    J Neurol. 2021 Feb 1. pii: 10.1007/s00415-021-10400.
    PubMed         Abstract available

    Magn Reson Med

  7. PIREDDA GF, Hilbert T, Granziera C, Bonnier G, et al
    Quantitative brain relaxation atlases for personalized detection and characterization of brain pathology.
    Magn Reson Med. 2020;83:337-351.
    PubMed         Abstract available

  8. JANG H, Ma Y, Searleman AC, Carl M, et al
    Inversion recovery UTE based volumetric myelin imaging in human brain using interleaved hybrid encoding.
    Magn Reson Med. 2020;83:950-961.
    PubMed         Abstract available

    Mult Scler

  9. Incidence and clinical outcome of Coronavirus disease 2019 in a cohort of 11,560 Brazilian patients with multiple sclerosis.
    Mult Scler. 2021 Feb 2:1352458520978354. doi: 10.1177/1352458520978354.
    PubMed         Abstract available

  10. NYIRENDA MH, Fadda G, Healy LM, Mexhitaj I, et al
    Pro-inflammatory adiponectin in pediatric-onset multiple sclerosis.
    Mult Scler. 2021 Feb 1:1352458521989090. doi: 10.1177/1352458521989090.
    PubMed         Abstract available

    Nat Med

  11. STOWER H
    A functioning vaccine in mouse models of multiple sclerosis.
    Nat Med. 2021 Feb 1. pii: 10.1038/d41591-021-00006.


  12. BROWNLEE WJ, Galetta S
    Optic Nerve in Multiple Sclerosis Diagnostic Criteria: An Aye to the Eyes?
    Neurology. 2021;96:139-140.

  13. SORMANI MP, Tur C, Barkhof F
    Ibudilast: A Paradigm Shift for Progressive Multiple Sclerosis?
    Neurology. 2021;96:141-142.

    PLoS One

  14. THALER C, Kyselyova AA, Faizy TD, Nawka MT, et al
    Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging.
    PLoS One. 2021;16:e0245844.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  15. KENISON JE, Jhaveri A, Li Z, Khadse N, et al
    Tolerogenic nanoparticles suppress central nervous system inflammation.
    Proc Natl Acad Sci U S A. 2020;117:32017-32028.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.